TNF-α plays a central role in most inflammatory responses and it is a validated target for drugs against a number of chronic inflammatory disorders resulting from immune dysregulations such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis (RA), [7,24,25]. The gene discussed is TNF; the disease is ankylosing spondylitis.